Form 4: Berkshire Hathaway Trims DaVita Stake

Berkshire Hathaway Inc. reported a sale of 401,514 shares of DaVita Inc. common stock for approximately $54.3 million.

Summary

• Berkshire Hathaway Inc. disposed of 401,514 shares of DaVita Inc. common stock.
• The transaction occurred on October 27, 2025, at a price of $135.3558 per share.
• The total value of the shares sold was approximately $54,349,980.
• Following this transaction, Berkshire Hathaway Inc. beneficially owns 31,759,065 shares of DaVita Inc.
• The shares are held indirectly through subsidiaries: 15,126,977 by Government Employees Insurance Company and 16,632,088 by BNSF Master Retirement Trust and Berkshire Hathaway Inc. Consolidated Pension Plan.
• Warren E. Buffett, as the controlling stockholder of Berkshire, disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 4

Explanation: The sale of a significant number of shares by a major, long-term investor like Berkshire Hathaway is generally viewed as a negative signal, indicating a potential reduction in conviction or a strategic portfolio adjustment. While the remaining stake is substantial, the transaction itself is a divestment.

Positives

• The remaining substantial stake of 31,759,065 shares indicates continued significant investment in DaVita Inc. by Berkshire Hathaway, despite the partial divestment.

Negatives

• Berkshire Hathaway Inc., a significant 10% owner, reduced its stake in DaVita Inc. by selling 401,514 shares.
• The sale of shares by a prominent investor like Berkshire Hathaway could be interpreted as a signal of reduced conviction or a strategic reallocation of capital.

Risks

• No specific risks related to DaVita's operations or financial health are mentioned in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding DaVita Inc.'s future performance or Berkshire Hathaway's investment strategy beyond the reported transaction.

Management Comments

• Warren E. Buffett, on behalf of himself and each other reporting person, disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and disclaims beneficial ownership in shares held by pension plans.

Industry Context

DaVita Inc. operates in the healthcare sector, primarily providing kidney dialysis services. Berkshire Hathaway's partial divestment could reflect a strategic portfolio rebalancing or a response to specific market conditions within the healthcare industry, though the filing itself does not provide explicit reasons.

Comparison to Industry Standards

• This Form 4 filing, detailing an insider stock transaction, does not provide information suitable for a direct comparison to industry-specific operational or financial benchmarks. It reports a change in beneficial ownership by a major investor, which is a standard disclosure requirement for public companies.

Related Party Transactions

• The beneficial ownership structure involves Berkshire Hathaway Inc.'s subsidiaries (Government Employees Insurance Company and pension plans), which is a standard disclosure for large corporate entities and not a new related-party transaction in the context of this sale.

Stakeholder Impact

• Shareholders: Existing shareholders may view the sale by a major investor as a negative signal, potentially leading to downward pressure on the stock price.
• Investment Community: Analysts and institutional investors will likely scrutinize the reasons behind Berkshire Hathaway's partial divestment, potentially influencing their ratings and investment decisions for DaVita Inc.

Next Steps

• The filing does not specify any future actions, events, or milestones for DaVita Inc. or Berkshire Hathaway Inc. beyond the reported transaction.

Key Dates

Recommendation

The sale of over $54 million worth of shares by a highly influential 10% owner like Berkshire Hathaway Inc. signals a potential reduction in conviction or a strategic portfolio rebalancing. While the remaining stake is still substantial, such a divestment by a sophisticated investor often precedes or reflects underlying concerns, making a 'sell' recommendation prudent for investors to consider reducing exposure or re-evaluating their position in DaVita Inc.

Keywords

DaVita, DVA, Berkshire Hathaway, Warren Buffett, Form 4, insider transaction, stock sale, healthcare, kidney care, beneficial ownership